Study to Evaluate the Effect on Lung Function and ECG When a Combination of Tiotropium Plus Olodaterol is Administered to Patients With COPD Either From a Single Inhaler or Each Compound is Administered After Each Other From Two Different Inhalers

Summary

The primary objective of this study is to evaluate the efficacy and safety of orally inhaled tiotropium and olodaterol as both a fixed dose combination and a free combination with respect to lung function and ECG parameters

Timeline

Start

2014-01

Primary completion

2014-06

Completion

2014-06

Outcome

Met primary endpoint

registry analysis (superiority or other test); Placebo vs Tio+Olo 5/5μg; p <0.0001; Adjusted mean difference 0.219 (95% CI 0.187 to 0.252) NCT02030535 ↗

Drugs

Indications